Ryvu Therapeutics S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was PLN 36.950 million compared to PLN 33.720 million a year ago. Operating loss was PLN 35.697 million compared to PLN 45.385 million a year ago. Net loss was PLN 31.687 million compared to net income of PLN 285.640 million a year ago.